AU2914889A - Prophylaxis and therapy of acquired immunodeficiency syndrome - Google Patents
Prophylaxis and therapy of acquired immunodeficiency syndromeInfo
- Publication number
- AU2914889A AU2914889A AU29148/89A AU2914889A AU2914889A AU 2914889 A AU2914889 A AU 2914889A AU 29148/89 A AU29148/89 A AU 29148/89A AU 2914889 A AU2914889 A AU 2914889A AU 2914889 A AU2914889 A AU 2914889A
- Authority
- AU
- Australia
- Prior art keywords
- prophylaxis
- therapy
- acquired immunodeficiency
- immunodeficiency syndrome
- syndrome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 208000030507 AIDS Diseases 0.000 title 1
- 238000011321 prophylaxis Methods 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A61K39/4611—
-
- A61K39/464838—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9064687A | 1987-08-28 | 1987-08-28 | |
US090646 | 1987-08-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2914889A true AU2914889A (en) | 1989-04-17 |
Family
ID=22223672
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU29148/89A Abandoned AU2914889A (en) | 1987-08-28 | 1988-08-26 | Prophylaxis and therapy of acquired immunodeficiency syndrome |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2914889A (en) |
WO (1) | WO1989002277A2 (en) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6074650A (en) * | 1985-06-24 | 2000-06-13 | Hoechst Aktiengesellschaft | Membrane anchor/active compound conjugate, its preparation and its uses |
DE3937412A1 (en) * | 1989-11-10 | 1991-05-16 | Hoechst Ag | SYNTHETIC VACCINE FOR THE SPECIFIC INDUCTION OF CYTOTOXIC T-LYMPHOZYTES |
US6024964A (en) * | 1985-06-24 | 2000-02-15 | Hoechst Aktiengesellschaft | Membrane anchor/active compound conjugate, its preparation and its uses |
US5939074A (en) * | 1986-12-30 | 1999-08-17 | The United States Of America As Represented By The Department Of Health And Human Services | Multideterminant peptide antigens |
US5128319A (en) * | 1987-08-28 | 1992-07-07 | Board Of Regents, The University Of Texas System | Prophylaxis and therapy of acquired immunodeficiency syndrome |
DE346022T1 (en) * | 1988-06-10 | 1990-05-23 | Medical Research Council, London | PEPTIDE FRAGMENTS OF HIV. |
FR2650954B1 (en) * | 1989-08-18 | 1992-02-28 | Pasteur Institut | COMPOSITION RESULTING FROM THE BINDING OF AN EPITOPE B OF THE ENVELOPE GLYCOPROTEIN OF A TYPE IV RETROVIRUS AND A T-EPITOPE HAVING A DISTINCT PROTEIN ENCODED BY THIS RETROVIRUS AND THEIR APPLICATION TO THE PRODUCTION OF PROTECTIVE ANTIBODIES AGAINST AIDS |
CA2025634A1 (en) * | 1989-09-19 | 1991-03-20 | Thomas Fuerst | Peptides including ctl epitopes of hiv proteins and use thereof |
US6248574B1 (en) * | 1989-12-13 | 2001-06-19 | Avigdor Shaffermann | Polypeptides selectively reactive with antibodies against human immunodeficiency virus and vaccines comprising the polypeptides |
US5480967A (en) * | 1990-01-05 | 1996-01-02 | United Biomedical, Inc. | HIV-1 core protein fragments |
EP0527789A1 (en) * | 1990-04-03 | 1993-02-24 | Genentech, Inc. | Hiv envelope polypeptides |
DE69230106T2 (en) * | 1991-08-29 | 2000-03-30 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Rockville | PEPTIDE-ANTIGENE COMPOSED OF MULTI-DETERMINANTS THAT STIMULATE THE T-HELPER'S LYMPHOCYTE RESPONSE TO HIV IN A WIDE RANGE OF AFFECTED PEOPLE |
DK0671947T3 (en) * | 1991-12-02 | 2000-07-24 | Univ Texas | Preparations for triggering cytotoxic T lymphocyte responses to viruses |
JPH09510437A (en) * | 1993-12-28 | 1997-10-21 | カイロン ミモトープス プロプライエトリー リミテッド | T cell epitope |
WO1995020162A1 (en) * | 1994-01-19 | 1995-07-27 | The Government Of The United States Of America, Represented By The Secretary Of The Department Of Health And Human Services | Peptomers with enhanced immunogenicity |
DE4405810A1 (en) | 1994-02-23 | 1995-08-24 | Behringwerke Ag | Peptides derived from a retrovirus from the HIV group and their use |
US7935805B1 (en) | 1998-12-31 | 2011-05-03 | Novartis Vaccines & Diagnostics, Inc | Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof |
WO2000039304A2 (en) | 1998-12-31 | 2000-07-06 | Chiron Corporation | Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
CA2360347C (en) | 1998-12-31 | 2013-05-07 | Chiron Corporation | Improved expression of hiv polypeptides and production of virus-like particles |
ATE384795T1 (en) | 1998-12-31 | 2008-02-15 | Novartis Vaccines & Diagnostic | MODIFIED HIV ENV POLYPEPTIDES |
CA2452015C (en) | 2001-07-05 | 2012-07-03 | Chiron Corporation | Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
US20030170614A1 (en) | 2001-08-31 | 2003-09-11 | Megede Jan Zur | Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof |
JP2005521380A (en) | 2001-08-31 | 2005-07-21 | カイロン コーポレイション | Polynucleotide encoding antigenic type B HIV polypeptide, polypeptide and use thereof |
US6455670B1 (en) * | 2001-09-06 | 2002-09-24 | Tripep Ab | Pentamer peptide amide, ALGPG-NH2, that inhibits viral infectivity and methods of use thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0203676B1 (en) * | 1985-04-19 | 1992-01-29 | The Wistar Institute Of Anatomy And Biology | Vaccine for generating an immunogenic t cell response protective against a virus |
ES2056054T3 (en) * | 1986-09-19 | 1994-10-01 | Oncogen | USE OF ACTIVATED T-LYMPHOCYTES TO PREPARE A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF AIDS. |
WO1988005051A1 (en) * | 1986-12-30 | 1988-07-14 | United States Of America, Represented By The Unite | Synthetic peptides which induce cellular immunity of the aids virus and aids viral proteins |
AU599208B2 (en) * | 1986-12-31 | 1990-07-12 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | Method to predict antigenic sites recognized by t lymphocytes such as for design of vaccines |
EP0283327B1 (en) * | 1987-01-16 | 1997-06-25 | Institut Pasteur | Peptides with the immunological properties of HIV-2 |
-
1988
- 1988-08-26 WO PCT/US1988/002970 patent/WO1989002277A2/en unknown
- 1988-08-26 AU AU29148/89A patent/AU2914889A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1989002277A3 (en) | 1989-05-18 |
WO1989002277A2 (en) | 1989-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0491861A4 (en) | Prophylaxis and therapy of acquired immunodeficiency syndrome | |
AU2914889A (en) | Prophylaxis and therapy of acquired immunodeficiency syndrome | |
AU1467888A (en) | Agent for the prophylaxis and therapy of retroviral infections | |
AU1676588A (en) | Treatment of materials | |
HU902257D0 (en) | Products of relieving effect | |
AU1520188A (en) | Compositions and methods of treatment of timber | |
AU2467588A (en) | Surface treatment of refractories | |
AU6979487A (en) | Treatment of gases | |
AU2163388A (en) | Flame treatment | |
AU8015587A (en) | 4-amino-3-hydroxybutyronitrile and preparation of preparation of n-alkyl-3-pyrrolidinols | |
IL86302A0 (en) | Pharmaceutical combination for the prophylaxis and therapy of malaria | |
AU3604289A (en) | Treatment of arthritis | |
AU1279788A (en) | Compounds and treatment | |
EP0313654A4 (en) | Drug for prophylaxis and treatment of hepatopathy. | |
AU6660090A (en) | Treatment of depression | |
AU3836489A (en) | Treatment of immunodeficiency | |
AU3553489A (en) | Novel compounds and treatment | |
AU2564688A (en) | Treatment of fibromyalgia | |
AU8083591A (en) | Therapy and prophylaxis of autoimmune diseases | |
AU581120B2 (en) | An article of furniture | |
JPS6450846A (en) | Arylbisperfluoroalkylcarbinol and manufacture of same | |
GB8722529D0 (en) | Treatment of burns | |
AU3531889A (en) | Treatment of acquired immunodeficiency syndrome | |
AU1203888A (en) | Treatment of timber | |
GB8806481D0 (en) | Treatment of ulcers |